Dietmar Rieder
- Molecular Biology top 2%
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Cancer Research top 1%
- Immunology top 2%
- Co-authors
- Zlatko TrajanoskiFrancesca FinotelloMirjana EfremovaHubert HacklPornpimol CharoentongClemens MayerMihaela AngelovaAlexandra Lusser
- Topics
- RNA modifications and cancer (15 papers)RNA Research and Splicing (13 papers)Cancer Immunotherapy and Biomarkers (11 papers)
- Cited by
- Cancer ResearchOncologyImmunology
- Journals
- Nucleic Acids ResearchJournal of Biological ChemistryAngewandte Chemie International Edition
- Partner nations
- AustriaUnited StatesFrance
In The Last Decade
Dietmar Rieder
51 papers receiving 5.1k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Molecular Biology 2.8k
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.8k
- Cancer Research 1.6k
- Immunology 1.5k
Countries citing papers authored by Dietmar Rieder
This map shows the geographic impact of Dietmar Rieder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dietmar Rieder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dietmar Rieder more than expected).
Fields of papers citing papers by Dietmar Rieder
This network shows the impact of papers produced by Dietmar Rieder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dietmar Rieder. The network helps show where Dietmar Rieder may publish in the future.
Co-authorship network of co-authors of Dietmar Rieder
This figure shows the co-authorship network connecting the top 25 collaborators of Dietmar Rieder. A scholar is included among the top collaborators of Dietmar Rieder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dietmar Rieder. Dietmar Rieder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 0 | |
| 4 | 5 | |
| 5 | 2 | |
| 6 | 9 | |
| 7 | 4 | |
| 8 | 11 | |
| 9 | 28 | |
| 10 | 2 | |
| 11 | 92 | |
| 12 | 18 | |
| 13 | 108 | |
| 14 | 7 | |
| 15 | 30 | |
| 16 | 34 | |
| 17 | 52 | |
| 18 | 351 | |
| 19 | 64 | |
| 20 | 36 |
About Dietmar Rieder
Dietmar Rieder is a scholar working on Cancer Research, Immunology and Molecular Biology, having authored 57 papers that have together received 5.2k indexed citations. Recurring topics across this work include RNA modifications and cancer (15 papers), RNA Research and Splicing (13 papers) and Cancer Immunotherapy and Biomarkers (11 papers). The work is most often cited by research in Cancer Research (1.6k citations), Oncology (2.0k citations) and Immunology (1.5k citations). Dietmar Rieder has collaborated with scholars based in Austria, United States and France. Frequent co-authors include Zlatko Trajanoski, Francesca Finotello, Mirjana Efremova, Hubert Hackl, Pornpimol Charoentong, Clemens Mayer, Mihaela Angelova, Alexandra Lusser, Thomas Amort and Ronald Micura. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.